Release from Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Concerning the Consolidated Financial Statements
Company Name : Egyptian International Pharmaceuticals (EIPICO)
ISIN Code : EGS38081C013
Reuters Code : PHAR.CA
Content :
Release from the company stating that the Board of Directors will approve the consolidated financial statements for the period ended 30/06/2019 at the next Board meeting.
The Release (135 KB)
ISIN Code : EGS38081C013
Reuters Code : PHAR.CA
Content :
Release from the company stating that the Board of Directors will approve the consolidated financial statements for the period ended 30/06/2019 at the next Board meeting.
The Release (135 KB)
Comments